Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Marijuana-derived compound targets pain, inflammation

21.08.2002


Researchers are developing a marijuana-derived synthetic compound to relieve pain and inflammation without the mood-altering side effects associated with other marijuana based drugs.



They say the compound could improve treatment of a variety of conditions, inctluding chronic pain, arthritis and multiple sclerosis. Their findings were presented at the 224th national meeting of the American Chemical Society, the world’s largest scientific society.

The compound, called ajulemic acid, has produced encouraging results in animal studies of pain and inflammation. It is undergoing tests in a group of people with chronic pain and could be available by prescription within two to three years, the researchers say.


"We believe that [the compound] will replace aspirin and similar drugs in most applications primarily because of a lack of toxic side effects," says Sumner Burstein, Ph.D., lead investigator in the study and a professor in the department of biochemistry and molecular pharmacology at the University of Massachusetts Medical School in Worcester. "The indications so far are that it’s safe and effective," he added.

At a safety trial of the compound conducted in France last year among 15 healthy volunteers, no clinically adverse events were reported, including gastrointestinal ulcers, which have been associated with other non-steroidal anti-inflammatory compounds such as aspirin and ibuprofen. No mood-altering effects were reported, Burstein said.

Ajulemic acid is being tested in Germany among a group of 21 patients with chronic severe pain. Results are not yet available.

In animal tests, the compound was 10 to 50 times more potent as a pain-killer than delta-9-tetrahydrocannabinol (THC), the main mood-altering ingredient of marijuana. Laboratory studies indicate that the compound, a synthetic derivative of THC, is more potent than aspirin and ibuprofen, says Burstein.

In rodent models of rheumatoid arthritis, the compound prevented joint damage associated with the disease. It could be a promising alternative to current drugs used to treat arthritis, such as COX-2 inhibitors, the researcher says. These compounds have been linked to adverse side effects, including heart attacks and stroke.

Tests of multiple sclerosis (MS) in rats have shown that the drug relieves muscle stiffness (spasticity) associated with the disease, just as natural marijuana has been shown to have a similar effect. Human studies of the drug’s effect on MS are planned.

Other evidence suggests the compound could slow the spread of cancer cells and prolong survival in mice with brain tumors. The U.S. Army is evaluating it as a topical drug to relieve the blistering effects of sulfur mustard gas.

How it works is still under investigation. The compound appears to suppress chemical mediators, such as prostaglandins and cytokines, which are known to cause inflammation, the researcher says.

With an increasing number of medically beneficial compounds being found in marijuana, researchers have been searching for years for ways to utilize these compounds therapeutically without its associated "high." They have had little success, until now.

Marinol®, the only FDA-approved, marijuana-derived drug, is available by prescription as an appetite stimulant for AIDS patients and for fighting nausea associated with cancer chemotherapy. But this drug, which is also a synthetic derivative of THC, has been reported to cause a "high" in some patients.

"Some people want the high," admits Burstein. "But the medical community wants efficacy without this effect."

The original discovery of ajulemic acid was supported by the National Institute on Drug Abuse. Indevus Pharmaceuticals, based in Lexington, Mass., is developing the drug itself under the name CT-3. Burstein owns patents on ajulemic acid.


The poster on this research, MEDI 333, will be presented at 9:00 a.m., Wednesday, Aug. 21, at the Hynes Convention Center, Hall B, during a general poster session.

Sumner H. Burstein, Ph.D., is a professor in the department of biochemistry and molecular pharmacology at the University of Massachusetts Medical School in Worcester, Mass.

— Mark T. Sampson

Charmayne Marsh | EurekAlert!

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

Im Focus: Optoelectronic Inline Measurement – Accurate to the Nanometer

Germany counts high-precision manufacturing processes among its advantages as a location. It’s not just the aerospace and automotive industries that require almost waste-free, high-precision manufacturing to provide an efficient way of testing the shape and orientation tolerances of products. Since current inline measurement technology not yet provides the required accuracy, the Fraunhofer Institute for Laser Technology ILT is collaborating with four renowned industry partners in the INSPIRE project to develop inline sensors with a new accuracy class. Funded by the German Federal Ministry of Education and Research (BMBF), the project is scheduled to run until the end of 2019.

New Manufacturing Technologies for New Products

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Innovative LED High Power Light Source for UV

22.06.2017 | Physics and Astronomy

Mathematical confirmation: Rewiring financial networks reduces systemic risk

22.06.2017 | Business and Finance

Spin liquids − back to the roots

22.06.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>